AR072889A1 - Combinacion coccidicida para uso veterinario - Google Patents

Combinacion coccidicida para uso veterinario

Info

Publication number
AR072889A1
AR072889A1 ARP090102918A ARP090102918A AR072889A1 AR 072889 A1 AR072889 A1 AR 072889A1 AR P090102918 A ARP090102918 A AR P090102918A AR P090102918 A ARP090102918 A AR P090102918A AR 072889 A1 AR072889 A1 AR 072889A1
Authority
AR
Argentina
Prior art keywords
combination
veterinary
coccidicide
birds
veterinary use
Prior art date
Application number
ARP090102918A
Other languages
English (en)
Inventor
Bernardo Lozano-Dubernard
Luis Ocampo-Camberos
Hector Salvador Sumano-Lopez
Ernesto Soto-Priante
David Sarfati-Mizrahi
Original Assignee
Avi Mex S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avi Mex S A De C V Lab filed Critical Avi Mex S A De C V Lab
Publication of AR072889A1 publication Critical patent/AR072889A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una combinacion con efectos anticoccidiandos formada por toltrazuril y trimetoprim. También se describen composiciones veterinarias donde se utiliza dicha combinacion, en donde las composiciones veterinarias tienen un efecto potenciado que hace que las aves se recuperan más rápido y tengan menos secuelas de la enfermedad y no presentan precipitacion de los ingredientes activos de la combinacion cuando son empleadas con aguas duras. Reivindicacion 5: Una composicion veterinaria coccidicida, de conformidad con la reivindicacion 3, caracterizada además porque la composicion veterinaria está formulada para administracion oral. Reivindicacion 12: El uso de una combinacion tal como se reclama en la reivindicacion 1 para la elaboracion de un medicamento util en el tratamiento de coccidiosis en aves o mamíferos.
ARP090102918A 2008-07-31 2009-07-30 Combinacion coccidicida para uso veterinario AR072889A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2008009818A MX2008009818A (es) 2008-07-31 2008-07-31 Combinacion coccidicida para uso veterinario.

Publications (1)

Publication Number Publication Date
AR072889A1 true AR072889A1 (es) 2010-09-29

Family

ID=41610000

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090102918A AR072889A1 (es) 2008-07-31 2009-07-30 Combinacion coccidicida para uso veterinario

Country Status (13)

Country Link
EP (1) EP2319515B1 (es)
AR (1) AR072889A1 (es)
BR (1) BRPI0911719A8 (es)
CL (1) CL2011000208A1 (es)
CO (1) CO6341549A2 (es)
DK (1) DK2319515T3 (es)
DO (1) DOP2011000030A (es)
ES (1) ES2475266T3 (es)
MX (1) MX2008009818A (es)
PE (1) PE20110401A1 (es)
PL (1) PL2319515T3 (es)
PT (1) PT2319515E (es)
WO (1) WO2010013129A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552477A (zh) * 2010-12-09 2012-07-11 天津瑞贝特科技发展有限公司 治疗鸡球虫病的中药组合物及其制备方法
ITTO20111219A1 (it) 2011-12-28 2013-06-29 Beta Renewables Spa Procedimento migliorato di pre-impregnazione per la conversione di biomassa
BR112017024363B1 (pt) * 2015-05-11 2023-03-14 Grupo Industrial Pecuario, S.A. De C.V Composições alimentícia compreendendo toltrazuril e trimetoprima e uso de uma combinação de toltrazuril e trimetoprima para o tratamento de parasitose por gregarinas em camarões

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454859B (sv) 1983-11-16 1988-06-06 Stig Olofsson Platta
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
BR9808114A (pt) * 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten

Also Published As

Publication number Publication date
MX2008009818A (es) 2010-02-01
DOP2011000030A (es) 2011-04-15
DK2319515T3 (da) 2014-06-30
CL2011000208A1 (es) 2011-05-06
PT2319515E (pt) 2014-05-27
BRPI0911719A2 (pt) 2015-10-06
EP2319515A1 (en) 2011-05-11
PL2319515T3 (pl) 2014-10-31
ES2475266T3 (es) 2014-07-10
PE20110401A1 (es) 2011-07-24
BRPI0911719A8 (pt) 2018-03-06
WO2010013129A1 (es) 2010-02-04
CO6341549A2 (es) 2011-11-21
EP2319515A4 (en) 2011-12-21
EP2319515B1 (en) 2014-05-07

Similar Documents

Publication Publication Date Title
DOP2013000105A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
ECSP088240A (es) Composición de trazodona para administración una vez por día
AR054064A1 (es) Composicio con ingrediente farmaceutico activo en base a canabinoide para formas de dosis mejoradas
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
ITBO20110012A1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
ECSP088866A (es) Uso de inhibidores de dpp iv
ES2525497T3 (es) Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico
AR060836A1 (es) Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
NZ585219A (en) Fast release solid formulation, preparation and use thereof
PE20081799A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
CR20120623A (es) Composiciones Farmacéuticas que comprenden Monohidrato de Lactato de 4-amino-5-Fluoro-3-[6-(4-Metil-Piperazin-1-Il)-1H- Bencimidazol-2-Il]-1H-Quinolin-2-Ona
UY31294A1 (es) Derivados de tetrahidrocarbozol, métodos para obtenerlos, formulaciones que los contienen y usos de los mismos
AR070025A1 (es) Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica
UY31780A (es) Fenoxibenzamidas sustituidas
AR068820A1 (es) Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica y uso
BRPI0912112B8 (pt) composição farmacêutica compreendendo composto tendo atividade antagonística em receptor de adenosina a2a útil em suprimir tolerância analgésica
AR070593A1 (es) Composiciones efervescentes
AR061233A1 (es) Formulacion de liberacion prolongada de naltrexona
AR072889A1 (es) Combinacion coccidicida para uso veterinario
AR065582A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR066666A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
AR057413A1 (es) Polvo desintegrable oralmente que comprende cilostazol
BR112012032463A2 (pt) composição farmacêutica para administração oral.
GT201000064A (es) Formulaciones galénicas de alisquireno

Legal Events

Date Code Title Description
FB Suspension of granting procedure